Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr
News

Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr

The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022

  • By IPP Bureau | November 19, 2022

Vivimed Labs Limited has posted net loss of Rs. 22.03 crores for the period ended September 30, 2022 as against net loss of Rs.  22.20 crores for the period ended June 30, 2022. The company posted net loss of Rs. 23.29 crores for the period ended September 30, 2021.

The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022 as compared to Rs. 50.18 crores during the period ended June 30, 2022. It reported total income of Rs.54.51 crores during the period ended September 30, 2021.

Vivimed Labs has reported total income of Rs.94.56 crores during the 6 Months period ended September 30, 2022 as compared to Rs.120.69 crores during the 6 Months period ended September 30, 2021.

The company has posted net loss of Rs.44.23 crores for the 6 Months period ended September 30, 2022 as against net loss of Rs.25.63 crores for the 6 Months period ended September 30, 2021.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International